Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-05-24 @ 7:56 PM
Study NCT ID:
NCT05845268
Status:
UNKNOWN
Last Update Posted:
2023-05-06
First Post:
2023-03-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Total Neoadjuvant Therapy Combined With Tislelizumab for Local Advanced of Middle and Low Rectal Cancer
Sponsor:
Beijing Friendship Hospital
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Locally Advanced Rectal Cancer | View |